Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioids in Cancer Chronic Pain
NCT00916890Phase 4Suspended
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Feb 2009
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of morphine, oxycodone, fentanyl (transdermal patch + oral transmucosal lozenge) and buprenorphine in chronic pain, sponsored by IRCCS San Matteo Foundation. Started Feb 2009; status: suspended.
02
Drugs
morphineoxycodonefentanyl (transdermal patch + oral transmucosal lozenge)buprenorphine
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00916890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916890.